This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mahmarian JJ, Dwivedi G, Lahiri T, et al. Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification. J Nucl Cardiol 2004;11:186–209.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361(9351):13–20.
Bolognese L, Cerisano G, Buonamici P, et al. Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction. Circulation 1997;96:3353–3359.
Shaw LJ, Peterson ED, Kesler K, et al. A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996;78:1327–1337.
Gibson RS, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321–336.
Boden WE, O’Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators [erratum in: N Engl J Med 1998;339:1091]. N Engl J Med 1998;338:1785–1792.
Dakik HA, Mahmarian JJ, Kimball KT, et al. Prognostic value of exercise 201Tl tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 1996;94:2735–2742.
Lima RSL, Watson DD, Goode AR, et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT MPI for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64–70.
Travin MI, Dessouki A, Cameron T, et al. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995;75:665–669.
Kroll D, Farah W, McKendall GR, et al. Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction. Am J Cardiol 2001;87:381–386.
Basu S, Senior R, Dore C, et al. Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients. BMJ 1996;313(7061):844–848.
Brown KA, Heller GV, Landin RS, et al. Early dipyridamole 99mTc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060–2066.
Chiamvimonvat V, Goodman SG, Langer A, et al. Prognostic value of dipyridamole SPECT imaging in lowrisk patients after myocardial infarction. J Nucl Cardiol 2001;8:136–143.
Sicari R, Landi P, Picano E, et al. EPIC (Echo Persantine International Cooperative); EDIC (Echo Dobutamine International Cooperative) Study Group. Exerciseelectrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study. Eur Heart J 2002;23:1030–1037.
Greco CA, Salustri A, Seccareccia F, et al. Prognostic value of dobutamine echocardiography early after uncomplicated acute myocardial infarction: a comparison with exercise electrocardiography. J Am Coll Cardiol 1997;29:261–267.
Carlos ME, Smart SC, Wynsen JC, et al. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997;95:1402–1410.
The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Thrombolysis in Myocardial Infarction. Circulation 1994;89:1545–1556.
FRagmin and Fast Revascularisation during In Stability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicenter study. Lancet 1999;354(9180):708–715.
Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. FRISC Investigators. Lancet 2000;356:9–16.
Goyal A, Samaha FF, Boden WE, et al. Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trial. J Am Coll Cardiol 2002;39:1601–1607.
Cannon CP, Weintraub WS, Demopoulos LA, et al. TACTICS (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879–1887.
Schwartz GG, Olsson AG, Ezekowitz MD, et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial [erratum in: JAMA 2001;286:536]. JAMA 2001;285:1711–1718.
Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855–860.
Yusuf S, Zhao F, Mehta SR, et al., Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation [erratum in: N Engl J Med 2001;345:1716 and N Engl J Med 2001;345:1506]. N Engl J Med 2001;345:494–502.
Dakik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 1998;98:2017–2023.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
Beller, G.A. (2006). Risk Stratification after Acute Coronary Syndromes. In: Anagnostopoulos, C.D., Nihoyannopoulos, P., Bax, J.J., van der Wall, E. (eds) Noninvasive Imaging of Myocardial Ischemia. Springer, London. https://doi.org/10.1007/1-84628-156-3_14
Download citation
DOI: https://doi.org/10.1007/1-84628-156-3_14
Publisher Name: Springer, London
Print ISBN: 978-1-84628-027-6
Online ISBN: 978-1-84628-156-3
eBook Packages: MedicineMedicine (R0)